Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Fine-Tuning Stem Cell Therapy to Repair the Heart

By BiotechDaily International staff writers
Posted on 27 Mar 2013
Print article
Stem cells have the potential to grow into a range of cell types, including heart cells. Researchers are now trying to refine the process of repairing and regenerating heart tissue damaged by a heart attack with stem cells.

A recent study from Cedars-Sinai Heart Institute (Los Angeles, CA, USA) suggests that stem cells may, undeniably, heal damaged hearts. The researchers treated 17 heart attack survivors with an infusion of stem cells taken from their own hearts. One year later, the amount of scar tissue had shrunk by about 50%. These findings look dramatic, but investigators are wondering if they an indication that they are close to perfecting stem cell therapy.

“This is a field where, depending on which investigator you ask, you can get incredibly different answers,” Dr. Richard Lee, professor of medicine at Harvard Medical School (Boston, MA, USA), and a leading specialist on stem cell therapy, reported in the March 2013 issue of Harvard Women’s Health Watch. “The field is young. Some studies show only modest or no improvement in heart function, but others have shown dramatically improved function. We’re waiting to see if other doctors can also achieve really good results in other patients.”

New research is generating contrary findings in part, because researchers use diverse approaches to harvest and use stem cells. Some are gathered from the bone marrow of donors, others from the recipient’s own heart. It is not evident which approach works optimally. “Some investigators think this is just a few years away,” concluded Dr. Lee. “And then there are others who feel that there is much more work to be done.”

Presently, stem cell therapy is available only to individuals who participate in a research trial.

Related Links:

Cedars-Sinai Heart Institute
Harvard Medical School




Print article

Channels

Genomics/Proteomics

view channel
Image: Molecular model of E3 ubiquitin ligase (green), E2 ubiquitin enzyme (orange), \"activated ubiquitin\" (cyan), and \"allosteric ubiquitin\" (blue) (Photo courtesy of Dr. Bernhard Lechtenberg, Sanford Burnham Prebys Medical Discovery Institute).

Researchers Resolve Molecular Structure of Critical Ubiquitin-Binding Enzyme

The molecular structure of a protein complex critically involved in diverse cellular functions such as cell signaling, DNA repair, and mounting anti-inflammatory and immune responses has been elucidated... Read more

Drug Discovery

view channel
Image: The “cellXpress” automated imaging analysis software enables to efficiently and accurately detect cellular responses (reflected in green) to nephrotoxic compounds (Photo courtesy of Agency for Science, Technology and Research (Singapore)).

First High-Throughput Imaging Platform for Predicting Kidney Toxicity of Chemicals

Researchers have developed a high-throughput platform of automated cellular imaging that efficiently and accurately predicts renal toxicity of chemical compounds without animal testing, providing an improved... Read more

Business

view channel

Purchase Agreement to Boost Ebola Vaccine Development

A deal to help boost development of a vaccine to protect against Ebolavirus infection was finalized at the recent Davos Conference in Switzerland. Gavi (Geneva, Switzerland), the global alliance for vaccines and immunizations, announced that it would spend five million USD to purchase the Ebola vaccine under development... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.